Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08HPU
|
||||
Former ID |
DNC006347
|
||||
Drug Name |
3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528109] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H15N
|
||||
Canonical SMILES |
CC1CC2=CC=CC=C2C=C1C3=CN=CC=C3
|
||||
InChI |
1S/C16H15N/c1-12-9-13-5-2-3-6-14(13)10-16(12)15-7-4-8-17-11-15/h2-8,10-12H,9H2,1H3
|
||||
InChIKey |
ARDWAGDGUKXSPH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [528109] | |
Cytochrome P450 19 | Target Info | Inhibitor | [528109] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Tryptophan metabolism | |||||
Ovarian Infertility Genes | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.